![Pamela Connealy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pamela Connealy
Direktor/Vorstandsmitglied bei
ORCHESTRA BIOMED HOLDINGS, INC.
Vermögen: 3 Mio $ am 30.06.2026
Profil
Pamela Yanchik Connealy is currently Director at Orchestra BioMed, Inc. since 2020 and Independent Non-Executive Director at Orchestra Biomed Holdings, Inc. since 2023.
Former roles include Global Head-Research & Development at Genentech, Inc. from 2002 to 2010, Vice President-Business Operations at Salesforce, Inc. from 2012 to 2013, Global Head-Talent at Gates Foundation Trust from 2014 to 2018, CFO, COO & Chief Human Resources Officer at Kiva Microfunds from 2018 to 2019, Chief Financial & Human Resources Officer at Immunovant, Inc. from 2019 to 2021, and Chief Operating & Financial Officer at Pyxis Oncology, Inc. from 2023 to 2025.
Education includes undergraduate studies at Gannon University and an MBA from the University of St. Thomas (Texas).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
PYXIS ONCOLOGY, INC. 1.27% | 20.04.2026 | 806’194 ( 1.27% ) | 2 Mio $ | 30.06.2026 |
| 28.04.2026 | 33’711 ( 0.06% ) | 145 463 $ | 30.06.2026 |
Aktive Positionen von Pamela Connealy
| Unternehmen | Position | Beginn |
|---|---|---|
| ORCHESTRA BIOMED HOLDINGS, INC. | Direktor/Vorstandsmitglied | 26.01.2023 |
Orchestra BioMed, Inc.
 Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Direktor/Vorstandsmitglied | 01.02.2020 |
Ehemalige bekannte Positionen von Pamela Connealy
| Unternehmen | Position | Ende |
|---|---|---|
| PYXIS ONCOLOGY, INC. | Finanzdirektor/CFO | 01.07.2025 |
| IMMUNOVANT, INC. | Finanzdirektor/CFO | 16.07.2021 |
Kiva Microfunds
 Kiva Microfunds Miscellaneous Commercial ServicesCommercial Services Engages in connecting people through lending to alleviate poverty | Finanzdirektor/CFO | 01.11.2019 |
Gates Foundation Trust
 Gates Foundation Trust Financial ConglomeratesFinance Foundation | Corporate Officer/Principal | 01.06.2018 |
| SALESFORCE, INC. | Corporate Officer/Principal | 01.11.2013 |
Ausbildung von Pamela Connealy
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Finance |
Salesforce, Inc.
 Salesforce, Inc. Packaged SoftwareTechnology Services Develops customer relationship management software technology | Technology Services |
Gannon University
 Gannon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of St. Thomas (Texas)
 University of St. Thomas (Texas) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiva Microfunds
Kiva Microfunds Miscellaneous Commercial ServicesCommercial Services Engages in connecting people through lending to alleviate poverty | Commercial Services |
Orchestra BioMed, Inc.
Orchestra BioMed, Inc. Medical SpecialtiesHealth Technology Develops transformative therapeutic products | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Orchestra Biomed Holdings, Inc.
 Orchestra Biomed Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures therapeutic devices and solutions for treatment of hypertension in cardiac patients | Health Technology |
Wählen Sie MarketScreener 
